Welcome!

AJAX & REA Authors: Piram Manickam, Subrahmanya SV, S Sangeetha, Bob Gourley, RealWire News Distribution

News Feed Item

AtheroNova Launches New Website

IRVINE, CA--(Marketwire - January 29, 2013) - AtheroNova Inc. (OTCQB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced the launch of its new website as of January 18, 2013. The website, www.atheronova.com, has significantly augmented content and graphics to enhance the user experience moving forward.

"We are launching this new site to allow investors and interested parties to follow the coming developments in the Company as we start the transition from pre-clinical to clinical stage," stated CEO Thomas W. Gardner. "In taking the next step in our web presence, we allow users to sign up to receive corporate communications and allow those interested in our lipid-modulation technology to follow us more closely. We invite everyone to log on and explore the new site to sign up for our news alert system http://www.atheronova.com/alerts."

AtheroNova commissioned service and technology solutions company Equisolve LLC. to design the website and manage its content.

About AtheroNova

AtheroNova Inc., through its wholly-owned subsidiary, AtheroNova Operations, Inc., is a biotechnology company focused on the discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits and to safely improve lipid profiles in humans. In addition to its lead compound AHRO-001, AtheroNova plans to develop multiple applications for its patents-pending therapies in market sectors that include: Cardiovascular Disease, Stroke, Peripheral Artery Disease, Dementia and Alzheimer's and Erectile Dysfunction, all of which have been linked to atherosclerosis. Atherosclerosis and its related pharmaceutical expenses for these indications cost consumers more than $41 billion annually in the United States alone. For more information, please visit www.AtheroNova.com.

Forward-Looking Statements

This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of AtheroNova's management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; significant fluctuations in expenses associated with clinical trials, failure to secure additional financing, the inability to complete regulatory filings with the Food and Drug Administration, general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; AtheroNova's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of AtheroNova's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

AtheroNova undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in AtheroNova's 2011 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).

Company Contact:
Thomas Gardner
CEO
Tel: (949) 476-1100

or

Mark Selawski
CFO
Tel: (949) 476-1100

Investor Contact:
Jeff Ramson
ProActive Capital Resources Group
Tel: 646-863-6341
Email: info@atheronova.com

More Stories By Marketwire .

Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Cloud Expo Breaking News
Enterprises can't close their doors just because integration tools won't cope with the volume of information that their systems produce. As each day goes by, their information will become larger and more complicated, and enterprises must constantly struggle to manage the integration of dozens (or hundreds) of systems. Apache Hadoop has quickly become the technology of choice for enterprises that need to perform complex analysis of petabytes of data, but few are aware of its potential to hand...
Companies around the world are collecting massive amounts of data everyday that’s sitting around and not being utilized. Take for example the fact that companies collect demographic and location-based data via mobile devices all the time, but have to figure out how to monetize that data. In this session, Joyent CTO and founder Jason Hoffman will examine the state of Big Data, taking a look at what we're doing now to discussing what's on the horizon, as companies prepare and realign their busines...
Planning scalable environments isn't terribly difficult, but it does require a change of perspective. During this session we'll broaden our views to think on an Internet Scale by dissecting a video publishing application built with The SoftLayer Platform, Message Queuing, Object Storage, and Drupal. By examining a scalable modular application build that can handle unpredictable traffic, you'll be able to grow your development arsenal and pick up a few strategies to apply to your own projects.
Learn about the complex regulations surrounding HIPAA compliance and other considerations for running sensitive data in the Cloud. In their session at the 12th International Cloud Expo, Ken Ziegler, CEO of Logicworks, and Frank Nydam, Director of Healthcare Solutions at VMware, will discuss the best practices for leveraging virtualization and cloud technologies without sacrificing security or compliance. Care providers, State and Federal entities, integrators and SaaS providers large and small...
Backup, Recovery, and Archiving (BURA) are critical elements for IT to address. BURA solutions need to address a broad spectrum of needs including data protection, regulatory compliance, and business continuity. Today's cloud based solutions can enable customers to procure and consume BURA as a service supported by EMC's latest technologies. At the end of Rich Place's session at 12th Cloud Expo | Cloud Expo New York [June 10-13, 2013], you will be able to: 1. Gain a full understanding of Backup,...
A recent study by analyst firm IDC reports that in 2012, 1.7 million cloud computing-related roles across the globe could not be filled due to the lack of training, certification and experience in the applicant pool. As the global demand for cloud and big data expertise increases, employers are finding it difficult to recruit talent, which is slowing down the ability for organizations to adopt, implement, and realize benefits from innovative platforms like OpenStack. In this session join Clo...
Cloud enables SMBs to access new, scalable resources – previously only available to enterprises – in flexible and cost-effective ways. McKinsey’s SMB Cloud Report projects the public cloud market to reach $40-$50 billion by 2015, with SMBs comprising 65% of public cloud spending in 2015. But selling cloud to SMBs raises the questions of who, what and how. In this session Manjula Talreja, VP of Cisco’s Global Cloud Business Development Team, will discuss the importance of knowing who SMB...
Compelling consumer applications are created every day. Are you ready for the IT implications both internally and externally? As your datacenter needs more capacity, the cloud will be critical to success. What are the key considerations to help plan for the needed capacity over time? And how can the cloud best work with your existing applications? In his General Session at the 12th International Cloud Expo, Brian Jawalka, Enterprise Solutions Architect at Rackspace Hosting, will open conversat...
Cloud computing is more than a buzz-phrase it’s a transformative IT paradigm shift. The emphasis in the cloud is on elasticity, scalability, agility and open. Not just open standards but open APIs and open source. The delivery of software is also going through a paradigm shift. Open source software was often a commoditization of a market leader; Unix to Linux or Oracle to MySQL what’s changing is that the iterative nature, user context and the motto of releasing early and often are driving real ...
These days, it seems that every cloud provider claims that cloud is safer than your traditional datacenter. Is it though? In his General Session at 12th Cloud Expo | Cloud Expo New York, McAfee expert Rishi Bhargava will help you explore and address the security challenges and considerations for public cloud (IaaS, PaaS and SaaS).